Sycamore Partners has been speaking with private credit firms about debt financing for a potential deal, despite an earlier ...

Walgreens Boots ( NASDAQ: WBA) pared a bit of its decline amid a report that private equity firm Sycamore Partners is talking to private equity confirms about debt financing for a potential takeover.

Walgreens Boots (NASDAQ:WBA) rose 1.6% after the drugstore chain's CEO responded to recent takeover speculation. Walgreens ...

Walgreens Boots Alliance's prospective sale to a private equity firm is " mostly dead ," sources told CNBC's David Faber, according to a Jan. 27 report from The Wall Street Journal. Here are five ...

Pharmacy chain Walgreens has been struggling for over a year and has been in talks to sell to Sycamore Partners, a deal that is now "mostly dead." Meanwhile, some independent pharmacies are opting to ...

Many finance professionals -- and not a few investors -- consider Walgreens a juicy target for private equity players. In fact, according to reporting from Bloomberg and The Financial Times in 2019, ...

Walgreens Boots Alliance Inc. shares fell sharply Monday after CNBC reported that a potential take-private deal with Sycamore Partners LLC is unlikely. Sycamore was reportedly in talks to purchase the ...

The Wall Street Journal previously reported that Walgreens and Sycamore Partners were discussing a deal that could be finalized early this year.

Walgreens Boots (NASDAQ:WBA) fell 6.6% on a report that a potential takeover by private equity from Sycamore Partners is likely not going to happen. "It's mostly dead," CNBC's David Faber said on ...

Shares of Walgreens Boots Alliance (WBA) are down about 3% to $11.49 in early trading after CNBC’s David Faber said on-air that his sources ...